Companies / Florida / Cadrenal Therapeutics

· rebuilt nightly from public records

Signal Sheet

Selling to Cadrenal Therapeutics? Who to reach and why now

Headquartered in Ponte Vedra, Florida, Cadrenal Therapeutics is a publicly listed pharmaceutical preparations company, founded 2022. It raised $8.8M in Jun 2026 and its filings name 13 officers. Everything below links to the record it came from.

Listed company · Pharmaceutical Preparations · Florida

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerQuang X. PhamSEC filing, Jun 2026Named officer in the filing; part of the buying group
Executive OfficerJohn P. SharpSEC filing, Jun 2026Named officer in the filing; part of the buying group
Executive OfficerJames J. FergusonSEC filing, Jun 2026Named officer in the filing; part of the buying group
Executive OfficerJeffrey S. ColeSEC filing, Jun 2026Named officer in the filing; part of the buying group
Executive OfficerMatthew SzotSEC filing, Apr 2026Named officer in the filing; part of the buying group
Executive OfficerJames FergusonSEC filing, Apr 2026Named officer in the filing; part of the buying group
Executive OfficerJeffrey ColeSEC filing, Apr 2026Named officer in the filing; part of the buying group
Executive OfficerMatthew K. SzotSEC filing, Dec 2025Named officer in the filing; part of the buying group
Chief Technology OfficerLee GoldenSEC filing, Jun 2026Technology and tooling decisions
Chief Technology OfficerJohn R. MurphySEC filing, Jun 2026Technology and tooling decisions
Chief Technology OfficerGlynn WilsonSEC filing, Jun 2026Technology and tooling decisions
Chief Technology OfficerSteven ZelenkofskeSEC filing, Apr 2026Technology and tooling decisions
Chief Technology OfficerLee S. GoldenSEC filing, Dec 2025Technology and tooling decisions
For sellersWhy Cadrenal Therapeutics is worth a call this quarterBuy Window: open · new leadership Sep 2026
Sep 24Sep 2026

New leadership

Officer or director change

New leadership
$8.8M

Raised

Equity raise reported to the SEC, Jun 2026. Money arrives before the spending plan does.

Capital
$21.2M6 months

Back-to-back raises

3 equity raises in 6 months. Repeat funding is a company buying for growth, not maintenance.

Pattern
Track Cadrenal Therapeutics with a free trial →Get the next signal the day it is filed or posted.
Email me the next Cadrenal Therapeutics signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Sep 24, 2026Officer or director changeNew leadershipSEC filing
Jun 30, 2026Raised $8.8M in equity from 1 investorsCapitalSEC filing
Apr 1, 2026Raised $7.9M in equity from 1 investorsCapitalSEC filing
Dec 16, 2025Raised $4.4M in equity from 4 investorsCapitalSEC filing

Reach Cadrenal Therapeutics with emails that land

Lakewave finds the right people at Cadrenal Therapeutics, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on Cadrenal Therapeutics with a free trial →

About Cadrenal Therapeutics

HeadquartersPonte Vedra, Florida, per the filing address
Industry groupPharmaceutical Preparations
Founded2022, DE
OwnershipListed company
Raise history$4.4M (Dec 2025) · $7.9M (Apr 2026) · $8.8M (Jun 2026)
Lakewave Rising8 · 2 kinds of evidence · rank in Florida after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Longeveron · 22Silo Pharma · 18Akari Therapeutics · 18Jupiter Neurosciences · 4TuHURA BiosciencesSee all 5 with a free trial →

Questions people ask

Did Cadrenal Therapeutics raise funding in 2026?

Yes. Cadrenal Therapeutics reported a $8.8M equity raise to the SEC on Jun 30, 2026 with 1 investors.

Who runs Cadrenal Therapeutics?

The company's SEC filing, Jun 2026 names Quang X. Pham (Executive Officer) among its officers.

Where is Cadrenal Therapeutics headquartered?

Ponte Vedra, Florida, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.